Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 entities : Eli lilly and company save search
Loxo Oncology at Lilly Announces Details of Presentations at the 2021 American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
presentation ema
Worldwide Menopause Industry to 2026 - Prevalence of Herbal Treatment for Menopause Presents Opportunities
Published: 2021-11-04 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 3.11%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
NVO | News | $125.45 -2.48% 1.8M
|
Health Technology
|
| O: -3.06%
H: 0.0%
C: 0.0%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: -0.42%
H: 0.38%
C: 0.37%
GSK | News | $40.755 -1.18% 660K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
ABBV | News | $168.51 -0.61% 920K
|
Health Technology
|
| O: -0.28%
H: 0.51%
C: 0.39%
treatment
Quanterix Corporation Releases Operating Results for Third Quarter of 2021
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
ABT | News | $106.78 -0.75% 2M
|
Health Technology
|
| O: 0.19%
H: 0.42%
C: 0.11%
QTRX | $15.58 -3.23% 82K
|
Health Technology
|
| O: 1.13%
H: 1.17%
C: -0.07%
results
Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
PODD | $167.17 -0.06% 130K
|
Health Technology
|
| O: -1.42%
H: 0.42%
C: -1.93%
revenue increase
Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
Published: 2021-11-04 (Crawled : 18:00) - biospace.com/
NVO | News | $125.45 -2.48% 1.8M
|
Health Technology
|
| O: 0.06%
H: 0.26%
C: 0.19%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
ALNY | $144.215 -1.27% 110K
|
Health Technology
|
| O: -0.24%
H: 7.69%
C: 7.59%
kidney
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-11-04 (Crawled : 09:00) - prnewswire.com
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
INCY | $51.4 -0.48% 380K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
new drug treatment application therapy drug
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.